Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

Mutation, drift and selection in single-driver hematologic malignancy: Example of secondary myelodysplastic syndrome following treatment of inherited neutropenia.

Wojdyla T, Mehta H, Glaubach T, Bertolusso R, Iwanaszko M, Braun R, Corey SJ, Kimmel M.

PLoS Comput Biol. 2019 Jan 7;15(1):e1006664. doi: 10.1371/journal.pcbi.1006664. eCollection 2019 Jan.

2.

Peripheral blood immunophenotyping in a large cohort of patients with Shwachman-Diamond syndrome.

Bezzerri V, Vella A, Gennaro GD, Ortolani R, Nicolis E, Cesaro S, Fabrizzi B, Bronte V, Corey SJ, Cipolli M.

Pediatr Blood Cancer. 2019 Jan 2:e27597. doi: 10.1002/pbc.27597. [Epub ahead of print]

PMID:
30604473
3.

Peering through zebrafish to understand inherited bone marrow failure syndromes.

Oyarbide U, Topczewski J, Corey SJ.

Haematologica. 2019 Jan;104(1):13-24. doi: 10.3324/haematol.2018.196105. Epub 2018 Dec 20. Review.

4.

Dynamins 2 and 3 control the migration of human megakaryocytes by regulating CXCR4 surface expression and ITGB1 activity.

Suraneni PK, Corey SJ, Hession MJ, Ishaq R, Awomolo A, Hasan S, Shah C, Liu H, Wickrema A, Debili N, Crispino JD, Eklund EA, Chen Y.

Blood Adv. 2018 Dec 11;2(23):3540-3552. doi: 10.1182/bloodadvances.2018021923.

5.

SRP54 and a need for a new neutropenia nosology.

Oyarbide U, Corey SJ.

Blood. 2018 Sep 20;132(12):1220-1222. doi: 10.1182/blood-2018-07-859959. No abstract available.

6.

Captopril mitigates splenomegaly and myelofibrosis in the Gata1low murine model of myelofibrosis.

Corey SJ, Jha J, McCart EA, Rittase WB, George J, Mattapallil JJ, Mehta H, Ognoon M, Bylicky MA, Summers TA, Day RM.

J Cell Mol Med. 2018 Sep;22(9):4274-4282. doi: 10.1111/jcmm.13710. Epub 2018 Jul 4.

7.

New monogenic disorders identify more pathways to neutropenia: from the clinic to next-generation sequencing.

Corey SJ, Oyarbide U.

Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):172-180. doi: 10.1182/asheducation-2017.1.172. Review.

8.

Mature Ovarian Teratoma After Treatment for Unilateral Retinoblastoma With Nonmutated RB1.

Collins B, Corey SJ.

J Pediatr Hematol Oncol. 2017 Aug;39(6):485-486. doi: 10.1097/MPH.0000000000000918. No abstract available.

PMID:
28719514
9.

Monosomy 7/del (7q) in inherited bone marrow failure syndromes: A systematic review.

Pezeshki A, Podder S, Kamel R, Corey SJ.

Pediatr Blood Cancer. 2017 Dec;64(12). doi: 10.1002/pbc.26714. Epub 2017 Jul 14. Review.

10.

Synonymous mutation in TP53 results in a cryptic splice site affecting its DNA-binding site in an adolescent with two primary sarcomas.

Austin F, Oyarbide U, Massey G, Grimes M, Corey SJ.

Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26584. Epub 2017 May 5.

11.

The Highs and Lows of Measuring Thrombopoietin in Aplastic Anemia.

Corey SJ.

Pediatr Blood Cancer. 2016 Apr;63(4):585-6. doi: 10.1002/pbc.25885. Epub 2016 Jan 6. No abstract available.

PMID:
26740061
12.

G-CSF and GM-CSF in Neutropenia.

Mehta HM, Malandra M, Corey SJ.

J Immunol. 2015 Aug 15;195(4):1341-9. doi: 10.4049/jimmunol.1500861. Review.

13.

Histiocytic clearance of neoplastic cells in acute promyelocytic leukemia.

Schafernak KT, Corey SJ.

Blood. 2014 Nov 6;124(19):3020. No abstract available.

14.

Systems approach to phagocyte production and activation: neutrophils and monocytes.

Mehta HM, Glaubach T, Corey SJ.

Adv Exp Med Biol. 2014;844:99-113. doi: 10.1007/978-1-4939-2095-2_6. Review.

15.

Systems biology of platelet-vessel wall interactions.

Chen Y, Corey SJ, Kim OV, Alber MS.

Adv Exp Med Biol. 2014;844:85-98. doi: 10.1007/978-1-4939-2095-2_5. Review.

16.

Systems hematology: an introduction.

Corey SJ, Kimmel M, Leonard JN.

Adv Exp Med Biol. 2014;844:3-10. doi: 10.1007/978-1-4939-2095-2_1.

PMID:
25480634
17.

Expanding the scope of drug repurposing in pediatrics: the Children's Pharmacy Collaborative.

Blatt J, Farag S, Corey SJ, Sarrimanolis Z, Muratov E, Fourches D, Tropsha A, Janzen WP.

Drug Discov Today. 2014 Nov;19(11):1696-1698. doi: 10.1016/j.drudis.2014.08.003. Epub 2014 Aug 19.

18.

Linking stress granulopoiesis to protein synthesis through GADD34.

Mehta HM, Corey SJ.

Immunol Cell Biol. 2014 Feb;92(2):102-4. doi: 10.1038/icb.2013.107. Epub 2014 Jan 14. No abstract available.

PMID:
24418816
19.

Pediatric myelodysplastic syndromes: they do exist!

Glaubach T, Robinson LJ, Corey SJ.

J Pediatr Hematol Oncol. 2014 Jan;36(1):1-7. doi: 10.1097/MPH.0000000000000046. Review.

PMID:
24345881
20.

Shockingly: the loss of Lyn leads to leakiness.

Corey SJ, Day RM.

Blood. 2013 Dec 12;122(25):4009-10. doi: 10.1182/blood-2013-10-533158.

21.

Cellular stress pathways in pediatric bone marrow failure syndromes: many roads lead to neutropenia.

Glaubach T, Minella AC, Corey SJ.

Pediatr Res. 2014 Jan;75(1-2):189-95. doi: 10.1038/pr.2013.197. Epub 2013 Nov 5. Review.

PMID:
24192702
22.

Neutropenia-associated ELANE mutations disrupting translation initiation produce novel neutrophil elastase isoforms.

Tidwell T, Wechsler J, Nayak RC, Trump L, Salipante SJ, Cheng JC, Donadieu J, Glaubach T, Corey SJ, Grimes HL, Lutzko C, Cancelas JA, Horwitz MS.

Blood. 2014 Jan 23;123(4):562-9. doi: 10.1182/blood-2013-07-513242. Epub 2013 Nov 1.

23.

Alternatively spliced, truncated GCSF receptor promotes leukemogenic properties and sensitivity to JAK inhibition.

Mehta HM, Futami M, Glaubach T, Lee DW, Andolina JR, Yang Q, Whichard Z, Quinn M, Lu HF, Kao WM, Przychodzen B, Sarkar CA, Minella A, Maciejewski JP, Corey SJ.

Leukemia. 2014 May;28(5):1041-51. doi: 10.1038/leu.2013.321. Epub 2013 Oct 30.

24.

Loss of the F-BAR protein CIP4 reduces platelet production by impairing membrane-cytoskeleton remodeling.

Chen Y, Aardema J, Kale S, Whichard ZL, Awomolo A, Blanchard E, Chang B, Myers DR, Ju L, Tran R, Reece D, Christensen H, Boukour S, Debili N, Strom TS, Rawlings D, Vázquez FX, Voth GA, Zhu C, Kahr WH, Lam WA, Corey SJ.

Blood. 2013 Sep 5;122(10):1695-706. doi: 10.1182/blood-2013-03-484550. Epub 2013 Jul 23.

25.

Granulocyte colony-stimulating factor receptor T595I (T618I) mutation confers ligand independence and enhanced signaling.

Mehta HM, Glaubach T, Long A, Lu H, Przychodzen B, Makishima H, McDevitt MA, Cross NC, Maciejewski J, Corey SJ.

Leukemia. 2013 Dec;27(12):2407-10. doi: 10.1038/leu.2013.164. Epub 2013 Jun 6. No abstract available.

PMID:
23739288
26.

Biochemical and functional significance of F-BAR domain proteins interaction with WASP/N-WASP.

Chen Y, Aardema J, Corey SJ.

Semin Cell Dev Biol. 2013 Apr;24(4):280-6. doi: 10.1016/j.semcdb.2013.01.005. Epub 2013 Feb 4. Review.

PMID:
23384583
27.

ELANE mutations in cyclic and severe congenital neutropenia: genetics and pathophysiology.

Horwitz MS, Corey SJ, Grimes HL, Tidwell T.

Hematol Oncol Clin North Am. 2013 Feb;27(1):19-41, vii. doi: 10.1016/j.hoc.2012.10.004. Epub 2012 Nov 7. Review.

28.

Lysosomal disruption preferentially targets acute myeloid leukemia cells and progenitors.

Sukhai MA, Prabha S, Hurren R, Rutledge AC, Lee AY, Sriskanthadevan S, Sun H, Wang X, Skrtic M, Seneviratne A, Cusimano M, Jhas B, Gronda M, MacLean N, Cho EE, Spagnuolo PA, Sharmeen S, Gebbia M, Urbanus M, Eppert K, Dissanayake D, Jonet A, Dassonville-Klimpt A, Li X, Datti A, Ohashi PS, Wrana J, Rogers I, Sonnet P, Ellis WY, Corey SJ, Eaves C, Minden MD, Wang JC, Dick JE, Nislow C, Giaever G, Schimmer AD.

J Clin Invest. 2013 Jan;123(1):315-28. doi: 10.1172/JCI64180. Epub 2012 Dec 3.

29.

Shwachman-Diamond syndrome: diarrhea, no longer required?

Andolina JR, Morrison CB, Thompson AA, Chaudhury S, Mack AK, Proytcheva M, Corey SJ.

J Pediatr Hematol Oncol. 2013 Aug;35(6):486-9. doi: 10.1097/MPH.0b013e3182667c13.

30.

Drug repurposing in pediatrics and pediatric hematology oncology.

Blatt J, Corey SJ.

Drug Discov Today. 2013 Jan;18(1-2):4-10. doi: 10.1016/j.drudis.2012.07.009. Epub 2012 Jul 23. Review.

PMID:
22835502
31.

BAR proteins in cancer and blood disorders.

Chen Y, Aardema J, Misra A, Corey SJ.

Int J Biochem Mol Biol. 2012;3(2):198-208. Epub 2012 May 18.

32.

Two SHIPs passing in the middle of the immune system.

Corey SJ, Mehta HM, Stein PL.

Eur J Immunol. 2012 Jul;42(7):1681-4. doi: 10.1002/eji.201242706.

33.

From famine to feast: sending out the clones.

Glaubach T, Corey SJ.

Blood. 2012 May 31;119(22):5063-4. doi: 10.1182/blood-2012-04-417287. No abstract available.

34.

The F-BAR protein CIP4 inhibits neurite formation by producing lamellipodial protrusions.

Saengsawang W, Mitok K, Viesselmann C, Pietila L, Lumbard DC, Corey SJ, Dent EW.

Curr Biol. 2012 Mar 20;22(6):494-501. doi: 10.1016/j.cub.2012.01.038. Epub 2012 Feb 21.

35.

Dasatinib synergizes with both cytotoxic and signal transduction inhibitors in heterogeneous breast cancer cell lines--lessons for design of combination targeted therapy.

Park BJ, Whichard ZL, Corey SJ.

Cancer Lett. 2012 Jul 1;320(1):104-10. doi: 10.1016/j.canlet.2012.01.039. Epub 2012 Feb 2.

36.

Loss of SHIP-1 protein expression in high-risk myelodysplastic syndromes is associated with miR-210 and miR-155.

Lee DW, Futami M, Carroll M, Feng Y, Wang Z, Fernandez M, Whichard Z, Chen Y, Kornblau S, Shpall EJ, Bueso-Ramos CE, Corey SJ.

Oncogene. 2012 Sep 13;31(37):4085-94. doi: 10.1038/onc.2011.579. Epub 2012 Jan 16.

PMID:
22249254
37.

How I treat childhood CML.

Andolina JR, Neudorf SM, Corey SJ.

Blood. 2012 Feb 23;119(8):1821-30. doi: 10.1182/blood-2011-10-380774. Epub 2011 Dec 30.

38.

G-CSF receptor activation of the Src kinase Lyn is mediated by Gab2 recruitment of the Shp2 phosphatase.

Futami M, Zhu QS, Whichard ZL, Xia L, Ke Y, Neel BG, Feng GS, Corey SJ.

Blood. 2011 Jul 28;118(4):1077-86. doi: 10.1182/blood-2009-12-261636. Epub 2011 Jun 2.

39.

Cancer cell migration: when red light switched to green.

Corey SJ, Yu J.

Asian J Androl. 2011 Mar;13(2):177-8. doi: 10.1038/aja.2010.176. Epub 2011 Jan 17. No abstract available.

40.

Slowly produced microRNAs control protein levels.

Whichard ZL, Motter AE, Stein PJ, Corey SJ.

J Biol Chem. 2011 Feb 11;286(6):4742-8. doi: 10.1074/jbc.M110.166348. Epub 2010 Nov 4.

41.

Cdc42-interacting protein 4 promotes breast cancer cell invasion and formation of invadopodia through activation of N-WASp.

Pichot CS, Arvanitis C, Hartig SM, Jensen SA, Bechill J, Marzouk S, Yu J, Frost JA, Corey SJ.

Cancer Res. 2010 Nov 1;70(21):8347-56. doi: 10.1158/0008-5472.CAN-09-4149. Epub 2010 Oct 12.

42.

The hematologists' Maltese Falcon.

Corey SJ.

Blood. 2010 Apr 22;115(16):3179-80. doi: 10.1182/blood-2010-01-264820. No abstract available.

43.

Dasatinib inhibits the growth of molecularly heterogeneous myeloid leukemias.

Guerrouahen BS, Futami M, Vaklavas C, Kanerva J, Whichard ZL, Nwawka K, Blanchard EG, Lee FY, Robinson LJ, Arceci R, Kornblau SM, Wieder E, Cayre YE, Corey SJ.

Clin Cancer Res. 2010 Feb 15;16(4):1149-58. doi: 10.1158/1078-0432.CCR-09-2416. Epub 2010 Feb 9.

44.

Hematopoiesis and its disorders: a systems biology approach.

Whichard ZL, Sarkar CA, Kimmel M, Corey SJ.

Blood. 2010 Mar 25;115(12):2339-47. doi: 10.1182/blood-2009-08-215798. Epub 2010 Jan 26. Review.

45.

The Cdc42-interacting protein-4 (CIP4) gene knock-out mouse reveals delayed and decreased endocytosis.

Feng Y, Hartig SM, Bechill JE, Blanchard EG, Caudell E, Corey SJ.

J Biol Chem. 2010 Feb 12;285(7):4348-54. doi: 10.1074/jbc.M109.041038. Epub 2009 Nov 17.

46.

Pediatric therapy-related myelodysplastic syndrome/acute myeloid leukemia: the MD Anderson Cancer Center experience.

Aguilera DG, Vaklavas C, Tsimberidou AM, Wen S, Medeiros LJ, Corey SJ.

J Pediatr Hematol Oncol. 2009 Nov;31(11):803-11. doi: 10.1097/MPH.0b013e3181ba43dc.

PMID:
19801947
47.

Are kinases factors in core binding factor leukemia?

Andolina JR, Corey SJ.

Leuk Lymphoma. 2009 Sep;50(9):1397-8. doi: 10.1080/10428190903174375. No abstract available.

PMID:
19672779
48.

Dasatinib synergizes with doxorubicin to block growth, migration, and invasion of breast cancer cells.

Pichot CS, Hartig SM, Xia L, Arvanitis C, Monisvais D, Lee FY, Frost JA, Corey SJ.

Br J Cancer. 2009 Jul 7;101(1):38-47. doi: 10.1038/sj.bjc.6605101. Epub 2009 Jun 9.

49.

The F-BAR protein CIP4 promotes GLUT4 endocytosis through bidirectional interactions with N-WASp and Dynamin-2.

Hartig SM, Ishikura S, Hicklen RS, Feng Y, Blanchard EG, Voelker KA, Pichot CS, Grange RW, Raphael RM, Klip A, Corey SJ.

J Cell Sci. 2009 Jul 1;122(Pt 13):2283-91. doi: 10.1242/jcs.041343. Epub 2009 Jun 9.

50.

Flow cytometric determination of Src phosphorylation in pediatric patients treated with dasatinib.

Guerrouahen BS, Wieder E, Blanchard EG, Lee FY, Aplenc R, Corey SJ.

Pediatr Blood Cancer. 2009 Dec;53(6):1132-5. doi: 10.1002/pbc.22083.

Supplemental Content

Loading ...
Support Center